Activity – Page 5

Novartis to buy Regulus Therapeutics for up to $1.7B

6 months ago talkbio0Tagged Acquisition (action), Goldcrest, Kidney Diseases, Novartis

Goldcrest, Novartis, Acquisition (action), Kidney Diseases

HHS lifts stop work order on Vaxart’s COVID-19 trial, continues funding for the 10,000-participant study

6 months ago talkbio0Tagged BARDA, Covid Vaccine, COVID19 (disease), Lifting, next-generation, oral pill vaccine, Phase 2b Trial, stop work, Vaccines, Vaxart

Vaxart, COVID-19 vaccine, oral pill vaccine, stop work order lifted, BARDA funding, 10, 000-participant study, Phase 2b trial, next-generation COVID vaccine

Keytruda around head and neck cancer surgery cuts chance of disease coming back

6 months ago talkbio0Tagged Episodic, Head, Keytruda, perioperative

Keytruda, Head, perioperative, Episodic

J&J reports durability data for bladder cancer ‘pretzel’ drug after FDA filing

6 months ago talkbio0Tagged Malignant neoplasm of urinary bladder, TAR 200, United States Food and Drug Administration, Urinary Bladder

Urinary Bladder, TAR 200, United States Food and Drug Administration, Malignant neoplasm of urinary bladder

Merck KGaA closes in on SpringWorks deal at $3.5B price point

6 months ago talkbio0Tagged Acquisition (action), deal, Gomekli, Infrequent, KGaA, Merck, SpringWorks

SpringWorks, Acquisition (action), KGaA, Infrequent, Gomekli, deal, Merck

New NIH grant rules override the Civil Rights Act of 1964, barring recipients from DEI activities

6 months ago talkbio0Tagged 1964, Changing, civil, Civil Rights Act, Condition, Diversity, federal, Israeli (population group), NIH, Policy, Protections, recipients, United States National Institutes of Health

United States National Institutes of Health, recipients, NIH, Policy, Diversity, Changing, Condition, civil, federal, civil, protections, recipients, Israeli (population group), Civil Rights Act, 1964